Medicis Pharmaceutical Corp. (MRX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $65.85 --0%
Revenue Growth %: +19.2%
Financial Fact:
Selling, general and administrative (2): 111.49M
Today's EPS Names:
FCNCA, PBCO, ARBV, More
Revenue Growth %: +19.2%
Financial Fact:
Selling, general and administrative (2): 111.49M
Today's EPS Names:
FCNCA, PBCO, ARBV, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q3 EPS of $0.96, $0.02 better than the analyst estimate of $0.94. Revenue for the quarter came in at $484.6 million versus the consensus estimate of $475.84 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe upgrades AT&T to Outperform as improving fundamentals outweigh Starlink risk
- Kearny Financial (KRNY) Misses Q4 EPS by 2c
- Acme United (ACU) Tops Q2 EPS by 41c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
